McKesson Appoints Tom Rodgers to Executive Vice President & Chief Strategy and Business Development Officer

Dave Schulte has been named Rodger’s successor to lead McKesson Ventures

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK) today announced Tom Rodgers has been appointed executive vice president and chief strategy and business development officer effective June 5, 2020. In his new role, Rodgers will also become a member of the company’s Executive Operating Team. Rodgers succeeds Bansi Nagji who stepped down from his role effective March 31, 2020.

“McKesson has a long history of evolving our company in meaningful ways that enable us to lead in a rapidly changing healthcare environment,” said Brian Tyler, CEO, McKesson Corporation. “Tom’s experience in both venture capital and large healthcare environments, will be extremely valuable to our leadership team as we continue to strengthen our core business and transform our company to create new opportunities to deliver future growth.”

As executive vice president and chief strategy and business development officer, Rodgers will have responsibility for the company’s overall strategic plan and initiatives, as well as key acquisitions and internal programs that drive financial performance, enhance innovation and deliver added value for our customers.

Rodgers currently serves as senior vice president and managing director for McKesson Ventures. Rodgers has more than twenty-five years of experience working in emerging companies, large healthcare environments as well as venture capital firms. Prior to McKesson Ventures, Tom served as Director, Strategic Investments, Cambia Health and was a partner at Advanced Technology Ventures, where he led the fund’s investments in healthcare technology. Tom previously worked for McKesson from 2001 to 2004 as Vice President, Corporate Strategy and Business Development. He holds an M.B.A. from the Wharton School and a B.A. from the University of Pennsylvania.

Additionally, Dave Schulte has been named Rodger’s successor to lead McKesson Ventures, McKesson’s strategic venture capital firm that focuses on investing in innovative approaches to address business challenges facing the healthcare industry.

Dave joined McKesson in 2015 and has most recently served as managing director for McKesson Ventures. Dave has more than 20 years of experience as an investor and investment banker, partnering with entrepreneurs to build innovative healthcare and technology businesses. Prior to joining McKesson, Schulte ran Kaiser Permanente Ventures where he helped to build the investment program from $20M to $400M of assets under management. Dave is a graduate of St. John's University and earned a Master of Public Policy degree from Harvard University.

About McKesson Corporation

McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by our ICARE shared principles, our employees work every day to innovate and deliver opportunities that make our customers and partners more successful — all for the better health of patients. McKesson has been named the “Most Admired Company” in the healthcare wholesaler category by FORTUNE, a “Best Place to Work” by the Human Rights Campaign Foundation, and a top military-friendly company by Military Friendly. For more information, visit www.mckesson.com.